Tumor Microenvironment Associated with Complete Response to Tislelizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma Reveals a Potentially Different Mechanism of Action

Yuqin Song(Peking University), Jun Zhu(Shanghai Medical College of Fudan University), Dehui Zou(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianfeng Zhou(Tongji Hospital), Lei Fan(Jiangsu Province Hospital), Quanli Gao(Zhengzhou University), Fangfang Lv(Fudan University Shanghai Cancer Center), Haiyan Yang(Zhejiang Cancer Hospital), Wei Li(Jilin University), Yun Zhang(Baylor College of Medicine), Dan Wang(Tianjin University of Traditional Chinese Medicine), Pei Zhang(Westlake University), Ting Liu(Chinese PLA General Hospital), Lei Wang(BeiGene (China)), Tengfei Liu(South China Agricultural University), Liudi Yang(BeiGene (China)), Zhirong Shen(BeiGene (China)), Quanshun Wang(Chinese People's Liberation Army), Haiyi Guo(Boston University), Huilai Zhang(Shanxi Medical University)
Blood
November 4, 2020
Cited by 4


Related Papers